Genetic profile of gliosarcomas

American Journal of Pathology

Volumn 156, Issue 2, 2000, Pages 425-432

  Reis, Rui M ^a   Könü Lebleblicioglu, Dilek ^b   Lopes, Jose Manuel ^c   Kleihues, Paul ^a   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P16; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GENETICS; CELL DIFFERENTIATION; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; GLIA; GLIOSARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYME; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0033889229     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64746-3     Document Type: Article

References (46)

1. Primary and secondary glioblastomas: From concept to clinical diagnosis
2. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas
3. Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas
4. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas
5. Genetic profile of the giant cell glioblastoma
6. Uber Entstehung und Bau der Hirngliome
7. Mixed glioblastoma multiforme and sarcoma. A clinicopathologic study of 26 radiation therapy oncology group cases
8. The new WHO classification of brain tumours
9. Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells
10. The glial and mesenchymal elements of gliosarcomas share similar genetic alterations
11. Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children Association with an activated K-ras gene
12. CDKN2/p 16 or RB alterations occur in the majority of glioblastomas and are inversely correlated
13. Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme
14. Amplification and overexpression of MDM2 in primary (de novo) glioblastomas
15. Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue
16. The endothelial hyperplasia of the cerebral blood vessels and its sarcomatous transformation
17. Gliosarcoma: An immunohistochemical study
18. Contribution of histiocytic cells to sarcomatous development of the gliosarcoma. An immunohistochemical study
19. Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme
20. Gliosarcoma: A histologic and immunohistochemical reaffirmation
21. Spindle-cell glioblastoma or gliosarcoma?
22. Interphase cytogenetics of glioblastoma and gliosarcoma
23. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors
24. p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: Implications for histogenesis
25. Clinicopathologic features of primary and postirradiation cerebral gliosarcoma
26. Gliosarcoma: A study of 13 tumors, including p53 and CD34 immunohistochemistry
27. Cytogenetics of human brain tumors
28. A cytogenetic study of 53 human gliomas
29. Relationship between gene amplification and chromosomal deviations in malignant human gliomas
30. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA
31. Platelet-derived growth factor in human glioma
32. Met and hepatocyte growth factor/scatter factor expression in human gliomas
33. Two independent amplification events on chromosome 7 in glioma: Amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET
34. Characterization of the 12q13-15 amplicon in soft tissue tumors
35. Gene amplification in human gliomas
36. Cancer cell cycles
37. The retinoblastoma gene family: Cousins with overlapping interests
38. CDKN2 (p16/ MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas
39. Human glioblastomas with no alterations of the CDK2A (p16(INK4A), MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene
40. p53 Mutations in human malignant gliomas: Comparison of loss of heterozygosity with mutation frequency
41. Molecular genetic analysis of giant cell glioblastomas
42. PTEN mutations in gliomas and glioneuronal tumors
43. Subsets of glioblastoma multiforme defined by molecular genetic analysis